Access the full text.
Sign up today, get DeepDyve free for 14 days.
D. Cattran, J. Feehally, H. Cook, Zhihong Liu, F. Fervenza, S. Mezzano, J. Floege, P. Nachman, D. Gipson, M. Praga, R. Glassock, J. Radhakrishnan, E. Hodson, B. Rovin, V. Jha, S. Troyanov, P. Li, J. Wetzels (2012)
NoticeKidney International Supplements, 2
Arbeitsgemeinschaft Nephrologie (2010)
Effect of cytotoxic drugs in frequently relapsing nephrotic syndrome with and without steroid dependence.The New England journal of medicine, 306 8
N. Webb, G. Lerner, B. Warady, K. Dell, L. Greenbaum, G. Ariceta, B. Hoppe, P. Linde, Ho-Jin Lee, A. Eldred, M. Dufek (2017)
Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney diseasePediatric Nephrology (Berlin, Germany), 32
R. Srivastava, Anand Vasudev, A. Bagga, K. Sunderam (1992)
Long-term, low-dose prednisolone therapy in frequently relapsing nephrotic syndromePediatric Nephrology, 6
G. Deschênes, M. Vivarelli, L. Peruzzi (2017)
Variability of diagnostic criteria and treatment of idiopathic nephrotic syndrome across European countriesEuropean Journal of Pediatrics, 176
B. Foster, J. Shults, B. Zemel, M. Leonard (2006)
Risk factors for glucocorticoid-induced obesity in children with steroid-sensitive nephrotic syndromePediatric Nephrology, 21
M. Hiraoka, H. Tsukahara, K. Matsubara, M. Tsurusawa, N. Takeda, S. Haruki, S. Hayashi, K. Ohta, Tohru Momoi, Y. Ohshima, N. Suganuma, M. Mayumi (2003)
A randomized study of two long-course prednisolone regimens for nephrotic syndrome in children.American journal of kidney diseases : the official journal of the National Kidney Foundation, 41 6
M. Broyer, F. Terzi, A. Lehnert, M. Gagnadoux, G. Guest, P. Niaudet (1997)
A controlled study of deflazacort in the treatment of idiopathic nephrotic syndromePediatric Nephrology, 11
T. Ulinski, Anne Carlier-Legris, Déborah Schlecht, B. Ranchin, P. Cochat (2005)
Triamcinolone acetonide: a new management of noncompliance in nephrotic childrenPediatric Nephrology, 20
AM Schijvens, EM Dorresteijn, Roeleveld Cja, ter Heine, van Jae, Bouts Ahm, MG Keijzer-Veen, van Ncaj, van Lpwj, MF Schreuder (2017)
REducing STEroids in Relapsing Nephrotic syndrome: the RESTERN study— protocol of a national, double-blind, randomised, placebo-controlled, non-inferiority intervention studyBMJ Open, 7
N. Teeninga, J. Holthe, Nienske Rijswijk, N. Mos, W. Hop, J. Wetzels, A. Heijden, J. Nauta (2013)
Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome.Journal of the American Society of Nephrology : JASN, 24 1
B. Ekka, A. Bagga, Rajendra Srivastava (1997)
Single- versus divided-dose prednisolone therapy for relapses of nephrotic syndromePediatric Nephrology, 11
N. Teeninga, Z. Guan, J. Stevens, J. Holthe, M. Ackermans, A. Heijden, R. Schaik, T. Gelder, J. Nauta (2016)
Population Pharmacokinetics of Prednisolone in Relation to Clinical Outcome in Children With Nephrotic SyndromeTherapeutic Drug Monitoring, 38
H. Barnett, H. Mcnamara, W. Mccrory, Forman Cw, M. Rapoport, Michie Aj, G. Barbero (1950)
The effects of ACTH and cortisone on the nephrotic syndrome.A.M.A. American journal of diseases of children, 80 3
M. Biniaminov, B. Ramot (1974)
POSSIBLE T-LYMPHOCYTE ORIGIN OF REED-STERNBERG CELLSThe Lancet, 303
I. Mahmoud, Fathi Basuni, A. Sabry, A. El-Husseini, N. Hassan, N. Ahmad, Mahmoud Elbaz, F. Moustafa, M. Sobh (2005)
Single-centre experience with cyclosporin in 106 children with idiopathic focal segmental glomerulosclerosis.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 20 4
M. Vivarelli, L. Massella, B. Ruggiero, F. Emma (2017)
Minimal Change Disease.Clinical journal of the American Society of Nephrology : CJASN, 12 2
A. Sinha, A. Saha, Manish Kumar, Sonia Sharma, K. Afzal, A. Mehta, M. Kalaivani, P. Hari, A. Bagga (2015)
Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome.Kidney international, 87 1
C. Gennari, B. Imbimbo, M. Montagnani, M. Bernini, P. Nardi, L. Avioli, L. Avioli (1984)
Effects of prednisone and deflazacort on mineral metabolism and parathyroid hormone activity in humansCalcified Tissue International, 36
R. Spencer, L. Chun, M. Hartsock, E. Woodruff (2017)
Glucocorticoid hormones are both a major circadian signal and major stress signal: How this shared signal contributes to a dynamic relationship between the circadian and stress systemsFrontiers in Neuroendocrinology, 49
E. Kuźma-Mroczkowska, P. Skrzypczyk, M. Pańczyk-Tomaszewska (2016)
Levamisole therapy in children with frequently relapsing and steroid-dependent nephrotic syndrome: a single-center experienceCentral-European Journal of Immunology, 41
A. Pasini, G. Aceto, A. Ammenti, G. Ardissino, Vitalba Azzolina, A. Bettinelli, E. Cama, S. Cantatore, A. Crisafi, G. Conti, M. D'Agostino, Alessandra Dozza, A. Edefonti, C. Fede, E. Groppali, Chiara Gualeni, A. Lavacchini, Marta Lepore, S. Maringhini, P. Mariotti, M. Materassi, F. Mencarelli, G. Messina, A. Negri, M. Piepoli, F. Ravaglia, A. Simoni, Laura Spagnoletta, G. Montini (2014)
Best practice guidelines for idiopathic nephrotic syndrome: recommendations versus realityPediatric Nephrology (Berlin, Germany), 30
N. Yoshikawa, K. Nakanishi, Mayumi Sako, M. Oba, R. Mori, E. Ota, K. Ishikura, H. Hataya, M. Honda, S. Ito, Yuko Shima, H. Kaito, K. Nozu, Hidefumi Nakamura, T. Igarashi, Y. Ohashi, K. Iijima (2014)
A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatmentKidney International, 87
M. Vacchio, J. Ashwell (1997)
Thymus-derived Glucocorticoids Regulate Antigen-specific Positive SelectionThe Journal of Experimental Medicine, 185
K. Kamei, K. Ishikura, Mayumi Sako, K. Aya, R. Tanaka, K. Nozu, H. Kaito, K. Nakanishi, Y. Ohtomo, K. Miura, Shori Takahashi, T. Morimoto, Wataru Kubota, S. Ito, Hidefumi Nakamura, K. Iijima, on group (2017)
Long-term outcome of childhood-onset complicated nephrotic syndrome after a multicenter, double-blind, randomized, placebo-controlled trial of rituximabPediatric Nephrology, 32
O. Motoyama, K. Iitaka (2007)
Final height in children with steroid‐sensitive nephrotic syndromePediatrics International, 49
A. Abeyagunawardena, R. Trompeter (2007)
Increasing the dose of prednisolone during viral infections reduces the risk of relapse in nephrotic syndrome: a randomised controlled trialArchives of Disease in Childhood, 93
A. Abeyagunawardena, R. Thalgahagoda, P. Dissanayake, S. Abeyagunawardena, Y. Illangasekera, U. Karunadasa, R. Trompeter (2017)
Short courses of daily prednisolone during upper respiratory tract infections reduce relapse frequency in childhood nephrotic syndromePediatric Nephrology, 32
Severin Kengne-Wafo, L. Massella, F. Diomedi-Camassei, A. Gianviti, M. Vivarelli, M. Greco, G. Stringini, F. Emma (2009)
Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.Clinical journal of the American Society of Nephrology : CJASN, 4 9
R. Trompeter, J. Hicks, B. Lloyd, R. White, J. Cameron (1985)
LONG-TERM OUTCOME FOR CHILDREN WITH MINIMAL-CHANGE NEPHROTIC SYNDROMEThe Lancet, 325
K. Drummond, A. Michael, R. Good, R. Vernier (1966)
The nephrotic syndrome of childhood: immunologic, clinical, and pathologic correlations.The Journal of clinical investigation, 45 4
D. Hahn, E. Hodson, N. Willis, Jonathan Craig (2015)
Corticosteroid therapy for nephrotic syndrome in children.The Cochrane database of systematic reviews, 3
J. Purton, J. Monk, D. Liddicoat, K. Kyparissoudis, S. Sakkal, S. Richardson, D. Godfrey, T. Cole (2004)
Expression of the Glucocorticoid Receptor from the 1A Promoter Correlates with T Lymphocyte Sensitivity to Glucocorticoid-Induced Cell Death1The Journal of Immunology, 173
L. Kaye, J. Kalenak, R. Price, R. Cunningham (1993)
Ocular implications of long-term prednisone therapy in children.Journal of pediatric ophthalmology and strabismus, 30 3
Sonia Azib, M. Macher, T. Kwon, A. Dechartres, C. Alberti, C. Loirat, G. Deschênes, V. Baudouin (2011)
Cyclophosphamide in steroid-dependent nephrotic syndromePediatric Nephrology, 26
M. Shenoy, N. Plant, M. Lewis, M. Bradbury, R. Lennon, N. Webb (2010)
Intravenous methylprednisolone in idiopathic childhood nephrotic syndromePediatric Nephrology, 25
M Broyer, C Kleinknecht (1978)
Journée Parisienne de Pédiatrie
N Webb, R Wooley, E Bretell, C Cummins, R Trompeter, E Barsoum, N Ives (2017)
Standard vs. extended course prednisolone therapy for the presenting episode of steroid sensitive nephrotic syndrome: the PREDNOS studyPediatr Nephrol, 32
J. Ksiazek, A. Niemirska, M. Lipka, R. Grenda (2006)
[Evaluation of arterial intima-media thickness (IMT) in children with idiopathic nephrotic syndrome--preliminary report].Przeglad lekarski, 63 Suppl 3
Hui Zhang, Z. Wang, Li-qun Dong, Yan-Nan Guo (2016)
Children with Steroid-resistant Nephrotic Syndrome: Long-term Outcomes of Sequential Steroid Therapy.Biomedical and environmental sciences : BES, 29 9
Riley Cm (1950)
The effect of adrenocorticotrophic hormone on salt and water excretion in children with the nephrotic syndrome.JAMA Pediatrics, 80
V. Baudouin, C. Alberti, Anne-Laure Lapeyraque, A. Bensman, J. André, F. Broux, M. Cailliez, S. Decramer, P. Niaudet, G. Deschênes, É. Jacqz-Aigrain, C. Loirat (2012)
Mycophenolate mofetil for steroid-dependent nephrotic syndrome: a phase II Bayesian trialPediatric Nephrology, 27
Karine Andréau, Christophe Lemaire, V. Souvannavong, Arlette Adam (1998)
Induction of apoptosis by dexamethasone in the B cell lineage.Immunopharmacology, 40 1
J. Luetscher, Q. Deming, J. Harvey, W. Lew, L. Poo (1950)
Treatment of nephrosis with cortisone.The Journal of clinical investigation, 29 12
Aishvarya Upadhyay, O. Mishra, R. Prasad, S. Upadhyay, F. Schaefer (2016)
Behavioural abnormalities in children with new-onset nephrotic syndrome receiving corticosteroid therapy: results of a prospective longitudinal studyPediatric Nephrology, 31
A. Gulati, A. Sinha, V. Sreenivas, Aparna Math, P. Hari, A. Bagga (2011)
Daily corticosteroids reduce infection-associated relapses in frequently relapsing nephrotic syndrome: a randomized controlled trial.Clinical journal of the American Society of Nephrology : CJASN, 6 1
D. Cain, J. Cidlowski (2017)
Immune regulation by glucocorticoidsNature Reviews Immunology, 17
P. Hoyer, Johannes Brodeh (2006)
Initial treatment of idiopathic nephrotic syndrome in children: prednisone versus prednisone plus cyclosporine A: a prospective, randomized trial.Journal of the American Society of Nephrology : JASN, 17 4
M. Zajączkowska, A. Papierkowski, A. Szczepanowska, Z. Zinkiewicz, H. Borzęcka, S. Zbarańska (2001)
[Influence of glucocorticoid steroid therapy on gastric and duodenal mucosa and Helicobacter pylori infection in children with nephrotic syndrome].Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego, 10 57
K. Eckardt, B. Kasiske (2012)
KDIGO Clinical Practice Guideline for Glomerulonephritis, 2
S. Gulati, K. Gulati (2004)
Bone disease in nephrotic syndrome—prevention is better than curePediatric Nephrology, 20
V. Leroy, V. Baudouin, C. Alberti, G. Guest, P. Niaudet, C. Loirat, G. Deschênes, P. Czernichow, D. Simon (2009)
Growth in boys with idiopathic nephrotic syndrome on long-term cyclosporin and steroid treatmentPediatric Nephrology, 24
A. Sellier-Leclerc, V. Baudouin, T. Kwon, M. Macher, V. Guérin, H. Lapillonne, G. Deschênes, T. Ulinski (2012)
Rituximab in steroid-dependent idiopathic nephrotic syndrome in childhood--follow-up after CD19 recovery.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 27 3
J. Ehrich, Christoph Geerlings, M. Zivicnjak, D. Franke, H. Geerlings, J. Gellermann (2007)
Steroid-resistant idiopathic childhood nephrosis: overdiagnosed and undertreated.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 22 8
P. Hari, A. Bagga, M. Mantan (2004)
Short term efficacy of intravenous dexamethasone and methylprednisolone therapy in steroid resistant nephrotic syndrome.Indian pediatrics, 41 10
M. Gruppen, A. Bouts, M. Weide, M. Merkus, A. Zurowska, M. Maternik, L. Massella, F. Emma, P. Niaudet, E. Cornelissen, T. Schurmans, A. Raes, J. Walle, M. Dyck, A. Gulati, A. Bagga, J. Davin (2017)
A randomized clinical trial indicates that levamisole increases the time to relapse in children with steroid-sensitive idiopathic nephrotic syndrome.Kidney international, 93 2
L. Dehoux, J. Hogan, C. Dossier, M. Fila, O. Niel, A. Maisin, M. Macher, T. Kwon, V. Baudouin, G. Deschênes (2016)
Mycophenolate mofetil in steroid-dependent idiopathic nephrotic syndromePediatric Nephrology, 31
R. Singhal, S. Pandit, Neeraj Dhawan (2015)
Deflazacort Versus Prednisolone: Randomized Controlled Trial in Treatment of Children With Idiopathic Nephrotic SyndromeIranian Journal of Pediatrics, 25
M. Zen, M. Canova, C. Campana, S. Bettio, L. Nalotto, M. Rampudda, R. Ramonda, L. Iaccarino, A. Doria (2011)
The kaleidoscope of glucorticoid effects on immune system.Autoimmunity reviews, 10 6
J. Simmonds, N. Grundy, R. Trompeter, K. Tullus (2010)
Long-term steroid treatment and growth: a study in steroid-dependent nephrotic syndromeArchives of Disease in Childhood, 95
A. Zagury, Anne Oliveira, Carlos Moraes, Jose Montalvão, Regina Novaes, Vinicius Sá, D. Carvalho, T. Matuck (2011)
Long-term follow-up after cyclophosphamide therapy in steroid-dependent nephrotic syndromePediatric Nephrology, 26
The use of steroids in idiopathic nephrotic syndrome is the major discovery of the twentieth century in the field of pediatric nephrology. At onset of the twenty-first century, steroids remain the first line of treatment at first flare. All the protocols to treat the first flare are similar by a common sequence including a first phase of daily prednisolone/prednisone at a dose of 60 mg/m2/day for at least 4 weeks followed by an alternate-day regimen for several weeks. It appears that a cumulated dose of 2240 mg/m2 given in 8 weeks at the first flare without tapering sequence is not inferior to increased dose and duration in terms of prevalence of frequent relapsers and the subsequent cumulated dose of steroids at 24 months of follow-up. A higher cumulated dose might only be interesting in patients aged below 4 years although a formal demonstration is still missing. Several retrospective studies are concordant to suggest that intravenous methylprednisolone pulses are useful to reach a full urinary remission in case of oral resistance to 4 weeks of oral prednisone/prednisolone. A majority of patients have multiple relapses after the treatment of the first flare and half meet the definition of steroid dependency. In those patients, long-lasting alternate-day prednisone/prednisolone therapy does not lead to long-lasting remission, opening the question of the best strategy of immunosuppression.
Pediatric Nephrology – Springer Journals
Published: Jun 4, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.